N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamideNitroxyl precursor CAS# 142867-52-5 |
- Phellodendrine chloride
Catalog No.:BCN5934
CAS No.:104112-82-5
- Lobetyolin
Catalog No.:BCN5894
CAS No.:136085-37-5
- Neferine
Catalog No.:BCN6338
CAS No.:2292-16-2
- Liensinine
Catalog No.:BCN6337
CAS No.:2586-96-1
- Orientin
Catalog No.:BCN4984
CAS No.:28608-75-5
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 142867-52-5 | SDF | Download SDF |
| PubChem ID | 688598 | Appearance | Powder |
| Formula | C10H10ClNO5S | M.Wt | 291.71 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble to 100 mM in DMSO | ||
| Chemical Name | [acetyl-(4-chlorophenyl)sulfonylamino] acetate | ||
| SMILES | CC(=O)N(OC(=O)C)S(=O)(=O)C1=CC=C(C=C1)Cl | ||
| Standard InChIKey | GWYBSWWLKXEDLB-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C10H10ClNO5S/c1-7(13)12(17-8(2)14)18(15,16)10-5-3-9(11)4-6-10/h3-6H,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | A pro-drug of the potent vasorelaxant nitroxyl, H-N=O, which it slowly releases in neutral solution. HNO eventually dimerizes and dehydrates to N2O, without producing NO. Also a powerful inhibitor of aldehyde dehydrogenase. |
N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide Dilution Calculator
N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.4281 mL | 17.1403 mL | 34.2806 mL | 68.5612 mL | 85.7016 mL |
| 5 mM | 0.6856 mL | 3.4281 mL | 6.8561 mL | 13.7122 mL | 17.1403 mL |
| 10 mM | 0.3428 mL | 1.714 mL | 3.4281 mL | 6.8561 mL | 8.5702 mL |
| 50 mM | 0.0686 mL | 0.3428 mL | 0.6856 mL | 1.3712 mL | 1.714 mL |
| 100 mM | 0.0343 mL | 0.1714 mL | 0.3428 mL | 0.6856 mL | 0.857 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Clausine D
Catalog No.:BCN4707
CAS No.:142846-95-5
- L-Sulforaphane
Catalog No.:BCN8449
CAS No.:142825-10-3
- Clinopodiside A
Catalog No.:BCN2621
CAS No.:142809-89-0
- Preapiodionene
Catalog No.:BCN1854
CAS No.:142808-39-7
- Apiodionene
Catalog No.:BCN1829
CAS No.:142808-38-6
- DPN
Catalog No.:BCC7088
CAS No.:1428-67-7
- 5,7-Dimethoxyluteolin
Catalog No.:BCN8167
CAS No.:90363-40-9
- Silybin B
Catalog No.:BCN7898
CAS No.:142797-34-0
- 4-Chlorophenylguanidine hydrochloride
Catalog No.:BCC2382
CAS No.:14279-91-5
- IWP-L6
Catalog No.:BCC5101
CAS No.:1427782-89-5
- Domoic acid
Catalog No.:BCC6586
CAS No.:14277-97-5
- 12-Hydroxysapriparaquinone
Catalog No.:BCN3216
CAS No.:142763-37-9
- Toddacoumaquinone
Catalog No.:BCN3640
CAS No.:142878-03-3
- U 73343
Catalog No.:BCC8091
CAS No.:142878-12-4
- GM 6001
Catalog No.:BCC2119
CAS No.:142880-36-2
- 1-O-Ethylpiptocarphin F
Catalog No.:BCN6448
CAS No.:142891-12-1
- 8alpha-Methacryloyloxy-13-ethoxyvernojalcanolide
Catalog No.:BCN7445
CAS No.:142891-14-3
- Petunidin chloride
Catalog No.:BCN3018
CAS No.:1429-30-7
- OXF BD 02
Catalog No.:BCC5598
CAS No.:1429129-68-9
- Mutant IDH1 inhibitor
Catalog No.:BCC4144
CAS No.:1429180-08-4
- Triptoquinone B
Catalog No.:BCN6238
CAS No.:142937-50-6
- Triptoquinone A
Catalog No.:BCN6781
CAS No.:142950-86-5
- HPOB
Catalog No.:BCC5574
CAS No.:1429651-50-2
- UNC2025
Catalog No.:BCC8062
CAS No.:1429881-91-3
Neuroprotective effects of KR-62980, a new PPARgamma agonist, against chemical ischemia-reperfusion in SK-N-SH cells.[Pubmed:21111719]
Brain Res. 2011 Feb 4;1372:103-14.
PPARgamma agonists exert neuroprotective effects against various types of brain injuries. In the present study, we investigated the effects of KR-62980, a new PPARgamma agonist, and rosiglitazone on the neuronal cell death induced by chemical ischemia-reperfusion in SK-N-SH cells and their underlying molecular mechanisms. Both agonists inhibited chemical ischemia-reperfusion-induced cell death, and the effects were associated with anti-apoptotic action. KR-62980 and rosiglitazone suppressed NO and ROS formation, and N-Acetyl-N-acetoxy-4-chlorobenzenesulfonamide, an NO generator, reversed the protective effects of the agonists on cell viability. In the agonist-induced anti-apoptotic process, PTEN expression was suppressed in parallel with increased Akt and ERK phosphorylation, whereas PD98059 (an ERK inhibitor) or wortmannin (a PI-3K inhibitor) abolished the cell survival by KR-62980 and rosiglitazone. All of the effects of KR-62980 and rosiglitazone appeared to be PPARgamma-dependent because the effects were reversed by bisphenol A diglycidyl ether, a PPARgamma antagonist, or by PPARgamma knockdown. Our results demonstrate that two PPARgamma agonists, KR-62980 and rosiglitazone, inhibited chemical ischemia-reperfusion-induced neuronal cell death by PPARgamma-mediated anti-apoptotic and anti-oxidant mechanisms related to PTEN suppression and ERK phosphorylation.
N,O-diacylated-N-hydroxyarylsulfonamides: nitroxyl precursors with potent smooth muscle relaxant properties.[Pubmed:1417812]
Biochem Biophys Res Commun. 1992 Sep 30;187(3):1367-73.
N,O-Diacylated-N-hydroxyarylsulfonamides are capable of slowly releasing nitroxyl (HNO) by simple, non-enzymatic hydrolysis in Krebs solution at 37 degrees C. Release of nitric oxide (NO) was not seen. These compounds were also found to elicit vasorelaxation in rabbit thoracic aorta in vitro, presumably as a result of their ability to release HNO. This effect was enhanced by the addition of superoxide dismutase (SOD). Thus, these results are consistent with previous work indicating that HNO is a potent vasorelaxant.
Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenase.[Pubmed:1433175]
J Med Chem. 1992 Oct 2;35(20):3648-52.
In the preceding paper, analogs of chlorpropamide with an OMe substituent on the sulfonamide nitrogen were shown to inhibit aldehyde dehydrogenase (AlDH), and it was postulated that these compounds were bioactivated by O-demethylation to release nitroxyl (HN = O, nitrosyl hydride), which is an inhibitor of AlDH. Further evidence for the production of nitroxyl from compounds with O-acyl instead of OMe on the sulfonamide nitrogen is now presented. Thus, nitrous oxide (N2O), the end product of nitroxyl dimerization and disproportionation, was found to be generated on alkaline or enzymatic hydrolysis of N,O-diacylated N-hydroxyarylsulfonamides. Since the latter compounds strongly inhibit yeast AlDH in vitro after bioactivation by an esterase intrinsic to this enzyme, nitroxyl generated from these compounds must be the common intermediate that inhibits AlDH.
